Huacong Cai

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Development and validation of a deep learning model to predict heparin response in critically ill patients with deep vein thrombosis receiving continuous intravenous heparin infusion.

Development and validation of a deep learning model to predict heparin response in critically ill patients with deep vein thrombosis receiving continuous intravenous heparin infusion.

Journal: Blood science (Baltimore, Md.)

Published: January 19, 2026

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Journal: Clinical and experimental immunology

Published: November 02, 2025

Real-World Comparative Analysis of Polatuzumab Vedotin-Based Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone versus Standard Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort Study.

Real-World Comparative Analysis of Polatuzumab Vedotin-Based Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone versus Standard Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort Study.

Journal: Oncology

Published: September 10, 2025

Inflammation, immunity and biomarkers in procoagulant responses of critically ill patients.

Inflammation, immunity and biomarkers in procoagulant responses of critically ill patients.

Journal: American journal of translational research

Published: July 01, 2024

Inflammation-Associated Coagulation Reactions are Associated with the Prognosis in Critically Ill Very Old Patients (VOPs) with Infection.

Inflammation-Associated Coagulation Reactions are Associated with the Prognosis in Critically Ill Very Old Patients (VOPs) with Infection.

Journal: Journal of inflammation research

Published: April 22, 2024

Corrigendum to "End Stage Renal Failure Patients With Hemophilia Treated With Peritoneal Dialysis: A Case Series" [Kidney International Reports Volume 7, Issue 12, December 2022, Pages 2639-2646].

Corrigendum to "End Stage Renal Failure Patients With Hemophilia Treated With Peritoneal Dialysis: A Case Series" [Kidney International Reports Volume 7, Issue 12, December 2022, Pages 2639-2646].

Journal: Kidney international reports

Published: February 12, 2024

The Prediction Value of D-Dimer on Prognosis in Intensive Care Unit among Old Patients ( ≥65 Years): A 9-Year Single-Center Retrospective Study of 9261 Cases.

The Prediction Value of D-Dimer on Prognosis in Intensive Care Unit among Old Patients ( ≥65 Years): A 9-Year Single-Center Retrospective Study of 9261 Cases.

Journal: Oxidative medicine and cellular longevity

Published: July 13, 2022

End Stage Renal Failure Patients With Hemophilia Treated With Peritoneal Dialysis: A Case Series.

End Stage Renal Failure Patients With Hemophilia Treated With Peritoneal Dialysis: A Case Series.

Journal: Kidney international reports

Published: March 04, 2022

Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.

Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.

Journal: European radiology

Published: June 09, 2020

Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study.

Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study.

Journal: Annals of hematology

Published: January 19, 2020

Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia.

Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia.

Journal: Annals of hematology

Published: January 12, 2020

Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study.

Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study.

Journal: American journal of hematology

Published: October 26, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026